Ivf Conference In Abu Dhabi Showcases Global Progress In Fertility Care And Innovation

The 2nd International Ferticlinic Fertility & IVF Conference opened in Abu Dhabi, confirming the emirate’s role as a major global centre for reproductive medicine and advanced fertility care. More than 2,000 attendees joined the first day, with over 65 international speakers examining how IVF, scientific research, and innovation are shaping patient-centred fertility services worldwide.

The meeting, themed "Abu Dhabi Leads the World in IVF Excellence", highlights the emirate’s progress in assisted reproductive technologies and outcomes. The event also reflects Abu Dhabi’s regulatory standards and emphasis on ethical medical practice, which have supported strong clinical performance and strengthened its position as a reference point in fertility care and IVF research.

Across two days, the 2nd IFFIC delivers a detailed scientific agenda that links theory and clinical application. Participants take part in interactive discussions with leaders in reproductive medicine, focusing on new treatment protocols and updated clinical evidence. Sessions also cover practical case discussions, giving healthcare professionals exposure to real-world scenarios in fertility care and complex IVF cases.

Keynote addresses from national and international health leaders form a central part of the IVF conference programme in Abu Dhabi. These talks highlight how medical innovation, careful governance, and data-driven decisions are influencing reproductive healthcare. Alongside them, specialised scientific tracks explore IVF developments, fertility preservation, genetics, fetal medicine, and approaches to complicated reproductive conditions.

Before the main sessions, IVF specialists and clinicians joined hands-on workshops in ultrasound, fetal medicine, and colposcopy. These training activities prepared participants for deeper conference debates by aligning clinical skills with current protocols. The programme ends with abstract presentations and scientific awards, offering researchers and emerging scientists a platform to present studies and exchange evidence-based findings.

The 2nd IFFIC also devotes time to artificial intelligence in fertility care, assessing practical uses and limitations. Speakers examine how AI tools may support embryo selection, outcome prediction, and personalised treatment planning. They also discuss data quality, regulatory oversight, and ethical safeguards, stressing that any AI integration in reproductive medicine must protect patients and remain scientifically robust.

Strategic healthcare vision at IVF conference Abu Dhabi

Dr. Nagwan Ahmed, Conference President, Professor of Obstetrics, Gynecology and Infertility, and Head of the Academics and Research Department at Ferticlinic Group, said, "The 2nd International Ferticlinic Fertility & IVF Conference reflects Abu Dhabi’s remarkable progress in reproductive medicine. This conference is designed not only to showcase scientific excellence, but also to foster global collaboration, support scientific research, and help shape the future of IVF through innovation, ethical practices, and patient-centered care."

Dr. Elsamawal El Hakim, Chief Executive Officer and Medical Director of the Ferticlinic Group, said, "Abu Dhabi has succeeded in building an integrated health ecosystem that combines clinical excellence, strong regulatory governance, innovation, and an enhanced patient experience. Through this scientific gathering, we aim to further solidify Abu Dhabi’s position as a global benchmark in IVF, research, and fertility education, while contributing to the advancement of sustainable healthcare both locally and internationally."

The 2nd International Ferticlinic Fertility & IVF Conference illustrates how Abu Dhabi links policy, clinical practice, and research within reproductive medicine. Through scientific sessions, workshops, AI discussions, and recognition of new studies, the meeting provides a structured platform for knowledge exchange. Outcomes from the 2nd IFFIC are expected to influence IVF practice and fertility education in Abu Dhabi and other healthcare systems.

With inputs from WAM